All of the latest happenings in the industry, all in one place.
KCR has named Douglas Bain as the organization’s Chief Technology Officer.
Mario Nacinovich has joined AiCure as the Global Head, Communications and Marketing.
Quotient Sciences has announced the appointment of Claes Glassell as non-executive chairman of its board of directors.
Pelican BioThermal announced the appointment of Ray Crane as Vice President of Worldwide Operations.
Experic announced the hire of Niyati Patel as the Director of Quality Assurance and Compliance.
Advanced Clinical is excited to announce that its global expansion into Europe continues with the opening of new offices in Bucharest and Timisoara, Romania.
CluePoints announced its expansion of two new larger offices in King of Prussia, US and Louvain-la-Neuve, Belgium.
Signant Health sponsored the Philadelphia Walk to End Alzheimer’s.
TrialScope announced their ClÄrus Award winners at TrialScope Transparency Experience.
Kayentis has announced the opening of a subsidiary in Japan.
Rho announced that it has been awarded a new federal contract from The National Institute of Dental and Craniofacial Research.
Pharmaceutical Product Development, LLC has been named Best CRO Provider for the second time in the
CluePoints at the 2019 EY Belgium awards
last three years at the World ADC Awards.
CluePoints is acknowledged as Scale up of the Year (Most Promising Company of the Year) at the recent 2019 EY Belgium awards.
4G Clinical was recognized as the Bio Supply Management Alliance (BSMA) Supply Chain Management Excellence and Innovation Award 2019 recipient for its utilization of natural language processing to turn study parameters into detailed forecasts.
Rho’s Kristin Gabor was honored at the Cystic Fibrosis Foundation’s annual “Brewer’s Ball Celebrating Triangle’s Finest.”
Moderna’s mRNA-1010 Flu Vaccine Meets Efficacy Goals in Phase III Trial of Adults 50+
July 10th 2025In the P304 Phase III study, Moderna’s mRNA-1010 demonstrated a 26.6% relative efficacy over a standard-dose flu vaccine in adults aged 50+, showing consistent protection across strains and age groups.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
QWINT-1 Trial: Once-Weekly Efsitora Matches Daily Glargine in Type 2 Diabetes Management
July 10th 2025Results from the Phase III QWINT-1 trial show that Eli Lilly’s once-weekly insulin efsitora is noninferior to once-daily glargine in reducing HbA1c among insulin-naïve adults with type 2 diabetes, offering a simplified fixed-dose regimen with fewer hypoglycemic events and less treatment burden.